States reach $26 billion deal with three wholesalers and J&J to end opioid lawsuits
12 days ago - By STAT
Three of the largest pharmaceutical wholesalers and a major drug maker reached a $26 billion deal to settle lawsuits accusing the companies of fomenting the opioid crisis, which has claimed half a million lives over nearly two decades.
As part of the settlement, the wholesalers - McKesson , AmerisourceBergen and Cardinal Health - will pay up to $21 billion over the next 18 years, while Johnson & Johnson agreed to pay up to $5 billion over nine years and exit the opioid business. More than 40 states are expected to agree to the settlement, according to North Carolina Attorney General Josh...
Read more ...
States and Cities Near Tentative $26 Billion Deal in Opioids Cases
12 days ago - By New York Times
The agreement would end thousands of lawsuits against the three largest distributors and Johnson & Johnson and require them to pay billions for addiction treatment and prevention.
Read more ...
Search by Tags
Health Drugs Breaking News Pharma Pharmalot Legal Opioids Pharmaceuticals Treatment Suits and Litigation States Pain-Relieving Drugs Opioids and Opiates Attorneys General AmerisourceBergen Corp Cardinal Health Inc Johnson & Johnson McKesson Corporation Compensation for Damages Drug Abuse and Traffic Addiction Your-feed-science
The headlines of Care Mag
The Best Alternatives If Retinol Is Too Harsh for Your Skin
Try these ingredients instead.
What to Do This Weekend
Set your intention for August.
The way we train doctors puts their mental health at risk: We need new solutions
This year has shown that being a doctor is no longer just about skill: it's about resilience, stamina, empathy, flexibility and teamwork. The way we educate medics needs to...
CEO of digital therapeutics business Freespira talks about its approach to...
Freespira CEO Dean Sawyer said its FDA cleared digital therapeutic is the first that's proven to significantly reduce or eliminate symptoms of panic attacks, panic disorder...
AC Immune picks up Phase 2-ready drug for Parkinson's in $58M deal with Affiris
AC Immune is bolstering the Parkinson's disease portion of its drug pipeline with a deal to acquire a therapeutic vaccine that Affiris is developing for the disorder...
Veda snags $45M to scale AI data processing platform for payers
The company's data processing platform can help payers comply with the law banning surprise billing, which requires insurers to process all provider directory updates in less...
The $87M push that could make or break our public health data system
If approved by Congress, ONC will receive $87 million for fiscal year 2022. With more funding, prominence, and demands, where should ONC place its focus?
This Underrated Grain May Help Manage Blood Sugar & Prevent Diabetes
Not all grains are created equal.
Is Love At First Sight Real? We Asked Marriage Therapists To Weigh In
The science behind the magic.
If Your Tinder Match Stopped Responding To You, Here's What To Do
It doesn't always happen, but sometimes you start messaging someone on a dating app and you just click. You and your match seem to have endless things to talk about. The...